Challenges of vaccine development include regulatory, technical, and manufacturing hurdles in translating a vaccine candidate into a commercial product.
Mar 2, 2012
By:
Anurag S. Rathore, Suresh Jadhav, Mahesh Bhalghat, Shiraz Kandawalla, Suma Ray, PhD, Ashok Kumar Patra
Challenges of vaccine development include regulatory, technical, and manufacturing hurdles in translating a vaccine candidate into a commercial product.
|
An evaluation of the technologies and process parameters needed to develop a safe, effective, and economically efficient vaccine. This article is part of a special section on vaccines.
Oct 2, 2011
By:
Suma Ray, PhD
An evaluation of the technologies needed to develop a safe, effective, and economically efficient vaccine. This article is part of a special section on vaccines.
|
How to implement a risk-based approach to eliminate viruses using orthogonal technologies.
Oct 2, 2009
By:
Suma Ray, PhD, Klaus Tarrach
How to implement a risk-based approach to eliminate viruses using orthogonal technologies.
|
How to implement a risk-based approach to eliminate viruses using orthogonal technologies.
Sep 1, 2008
By:
Suma Ray, PhD, Klaus Tarrach
How to implement a risk-based approach to eliminating viruses.
|
|
